Sleep apnea syndrome is significantly underdiagnosed in bariatric surgical patients

Jason J. Rasmussen, William D. Fuller, Mohamed R Ali

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Devastating morbidity and mortality can result when patients with undiagnosed sleep apnea syndrome (SAS) undergo bariatric surgery. We evaluated the prevalence of SAS and its rate of nondiagnosis in bariatric patients at a university hospital. Methods: The demographic, anthropomorphic, and co-morbidity data were collected from 1368 patients evaluated for bariatric surgery. All patients were screened for symptoms of SAS, and symptomatic patients were evaluated with polysomnography. Results: At the time of this report, 834 patients (61%) had completed the preoperative evaluation. Of these patients, 210 (25%) presented with previously diagnosed SAS. An additional 174 patients (21%) exhibited symptoms of SAS and underwent polysomnography. Most patients tested (127, 73%) had SAS that required treatment, 11 patients (6%) had mild SAS not requiring treatment, and 36 (21%) tested negative for SAS. Thus, symptom screening for SAS had a positive predictive value of 79% for predicting the presence of SAS and 73% for identifying patients who required SAS treatment. The patients with SAS tended to be older and male and have a greater body mass index (P <.05). Conclusion: Overall, SAS that required treatment with an oral appliance was prevalent (40%) in patients who presented for bariatric surgery. However, many of these patients with significant SAS (38%) were previously undiagnosed, despite exhibiting clear symptoms of the disease. Symptom screening appears to be effective in identifying patients who should be evaluated by polysomnography. To avoid the potential perils of undiagnosed SAS during the perioperative period, patients who undergo bariatric surgery should be screened, tested, and treated for this co-morbidity.

Original languageEnglish (US)
Pages (from-to)569-573
Number of pages5
JournalSurgery for Obesity and Related Diseases
Volume8
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Bariatrics
Sleep Apnea Syndromes
Bariatric Surgery
Polysomnography
Morbidity
Perioperative Period

Keywords

  • Bariatric surgery
  • Co-morbidity
  • Sleep apnea

ASJC Scopus subject areas

  • Surgery

Cite this

Sleep apnea syndrome is significantly underdiagnosed in bariatric surgical patients. / Rasmussen, Jason J.; Fuller, William D.; Ali, Mohamed R.

In: Surgery for Obesity and Related Diseases, Vol. 8, No. 5, 09.2012, p. 569-573.

Research output: Contribution to journalArticle

@article{7f8d6cf06ee84109b0586fa6e58d6a7d,
title = "Sleep apnea syndrome is significantly underdiagnosed in bariatric surgical patients",
abstract = "Background: Devastating morbidity and mortality can result when patients with undiagnosed sleep apnea syndrome (SAS) undergo bariatric surgery. We evaluated the prevalence of SAS and its rate of nondiagnosis in bariatric patients at a university hospital. Methods: The demographic, anthropomorphic, and co-morbidity data were collected from 1368 patients evaluated for bariatric surgery. All patients were screened for symptoms of SAS, and symptomatic patients were evaluated with polysomnography. Results: At the time of this report, 834 patients (61{\%}) had completed the preoperative evaluation. Of these patients, 210 (25{\%}) presented with previously diagnosed SAS. An additional 174 patients (21{\%}) exhibited symptoms of SAS and underwent polysomnography. Most patients tested (127, 73{\%}) had SAS that required treatment, 11 patients (6{\%}) had mild SAS not requiring treatment, and 36 (21{\%}) tested negative for SAS. Thus, symptom screening for SAS had a positive predictive value of 79{\%} for predicting the presence of SAS and 73{\%} for identifying patients who required SAS treatment. The patients with SAS tended to be older and male and have a greater body mass index (P <.05). Conclusion: Overall, SAS that required treatment with an oral appliance was prevalent (40{\%}) in patients who presented for bariatric surgery. However, many of these patients with significant SAS (38{\%}) were previously undiagnosed, despite exhibiting clear symptoms of the disease. Symptom screening appears to be effective in identifying patients who should be evaluated by polysomnography. To avoid the potential perils of undiagnosed SAS during the perioperative period, patients who undergo bariatric surgery should be screened, tested, and treated for this co-morbidity.",
keywords = "Bariatric surgery, Co-morbidity, Sleep apnea",
author = "Rasmussen, {Jason J.} and Fuller, {William D.} and Ali, {Mohamed R}",
year = "2012",
month = "9",
doi = "10.1016/j.soard.2011.06.021",
language = "English (US)",
volume = "8",
pages = "569--573",
journal = "Surgery for Obesity and Related Diseases",
issn = "1550-7289",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Sleep apnea syndrome is significantly underdiagnosed in bariatric surgical patients

AU - Rasmussen, Jason J.

AU - Fuller, William D.

AU - Ali, Mohamed R

PY - 2012/9

Y1 - 2012/9

N2 - Background: Devastating morbidity and mortality can result when patients with undiagnosed sleep apnea syndrome (SAS) undergo bariatric surgery. We evaluated the prevalence of SAS and its rate of nondiagnosis in bariatric patients at a university hospital. Methods: The demographic, anthropomorphic, and co-morbidity data were collected from 1368 patients evaluated for bariatric surgery. All patients were screened for symptoms of SAS, and symptomatic patients were evaluated with polysomnography. Results: At the time of this report, 834 patients (61%) had completed the preoperative evaluation. Of these patients, 210 (25%) presented with previously diagnosed SAS. An additional 174 patients (21%) exhibited symptoms of SAS and underwent polysomnography. Most patients tested (127, 73%) had SAS that required treatment, 11 patients (6%) had mild SAS not requiring treatment, and 36 (21%) tested negative for SAS. Thus, symptom screening for SAS had a positive predictive value of 79% for predicting the presence of SAS and 73% for identifying patients who required SAS treatment. The patients with SAS tended to be older and male and have a greater body mass index (P <.05). Conclusion: Overall, SAS that required treatment with an oral appliance was prevalent (40%) in patients who presented for bariatric surgery. However, many of these patients with significant SAS (38%) were previously undiagnosed, despite exhibiting clear symptoms of the disease. Symptom screening appears to be effective in identifying patients who should be evaluated by polysomnography. To avoid the potential perils of undiagnosed SAS during the perioperative period, patients who undergo bariatric surgery should be screened, tested, and treated for this co-morbidity.

AB - Background: Devastating morbidity and mortality can result when patients with undiagnosed sleep apnea syndrome (SAS) undergo bariatric surgery. We evaluated the prevalence of SAS and its rate of nondiagnosis in bariatric patients at a university hospital. Methods: The demographic, anthropomorphic, and co-morbidity data were collected from 1368 patients evaluated for bariatric surgery. All patients were screened for symptoms of SAS, and symptomatic patients were evaluated with polysomnography. Results: At the time of this report, 834 patients (61%) had completed the preoperative evaluation. Of these patients, 210 (25%) presented with previously diagnosed SAS. An additional 174 patients (21%) exhibited symptoms of SAS and underwent polysomnography. Most patients tested (127, 73%) had SAS that required treatment, 11 patients (6%) had mild SAS not requiring treatment, and 36 (21%) tested negative for SAS. Thus, symptom screening for SAS had a positive predictive value of 79% for predicting the presence of SAS and 73% for identifying patients who required SAS treatment. The patients with SAS tended to be older and male and have a greater body mass index (P <.05). Conclusion: Overall, SAS that required treatment with an oral appliance was prevalent (40%) in patients who presented for bariatric surgery. However, many of these patients with significant SAS (38%) were previously undiagnosed, despite exhibiting clear symptoms of the disease. Symptom screening appears to be effective in identifying patients who should be evaluated by polysomnography. To avoid the potential perils of undiagnosed SAS during the perioperative period, patients who undergo bariatric surgery should be screened, tested, and treated for this co-morbidity.

KW - Bariatric surgery

KW - Co-morbidity

KW - Sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=84866398567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866398567&partnerID=8YFLogxK

U2 - 10.1016/j.soard.2011.06.021

DO - 10.1016/j.soard.2011.06.021

M3 - Article

VL - 8

SP - 569

EP - 573

JO - Surgery for Obesity and Related Diseases

JF - Surgery for Obesity and Related Diseases

SN - 1550-7289

IS - 5

ER -